Page last updated: 2024-08-17

cycloheximide and Focal Segmental Glomerulosclerosis

cycloheximide has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bustos, C; Egido, J; Gómez-Garre, D; Largo, R; Ruiz-Ortega, M1
Chen, X; Cheng, Q; Fu, B; Li, W; Wang, J; Xu, Q; Ye, Y; Yu, L1

Other Studies

2 other study(ies) available for cycloheximide and Focal Segmental Glomerulosclerosis

ArticleYear
Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
    Journal of the American Society of Nephrology : JASN, 1997, Volume: 8, Issue:8

    Topics: Animals; Antibodies; Cells, Cultured; Collagen; Cycloheximide; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Platelet Activating Factor; Protein Kinase C; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Transforming Growth Factor beta

1997
Integrin alphavbeta3-RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells.
    Kidney international, 1999, Volume: 56, Issue:4

    Topics: Antibodies, Monoclonal; Cell Communication; Cell Division; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelium; Fibrin; Fibrinogen; Gelatin; Gels; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Oligopeptides; Platelet Aggregation Inhibitors; Protein Synthesis Inhibitors; Receptors, Vitronectin

1999